Agouron Pharmaceuticals reported a first-quarter loss of...
- Share via
Agouron Pharmaceuticals reported a first-quarter loss of $532,300 on revenue of $171,600, compared to a loss of $75,700 on revenue of $114,000 over the same three months last year. The loss was attributed to high development costs related to Agouron’s drug design technology.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
